Fibromyalgia
摘要
This article discusses the problem of studying fibromyalgia at the present stage, examines the application of the current criteria for the diagnosis and treatment of this disease.
参考
1. Табеева Г.Р. Нарушения сна у больных фибромиалгией // Русский медицинский журнал. 2006. Т. 14. № 21. 1530–1534.
2. Табеева Г.Р. Болевой синдром у больных фибромиалгией // Русский медицинский журнал. 2003. Т. 11. № 10. С. 586–589.
3. Табеева Г.Р. Фибромиалгия: формирование симптомов и принципы терапии // Неврология, нейропсихиатрия и психосоматика. 2012; 1: 23-27.
4. Ханунов И.Г. Клинико-психологическое, нейрофизиологическое исследование и фототерапия больных фибромиалгией. Автореф. дис. … канд. мед. наук. М., 2000. 23 с.
5. American Pain Society Guidelines for the management of fi bromyalgia syndrome pain in adults and children. Available from: http://www.ampainsoc.org/pub/fibromyalgia.htm.2005. Accessed Dec 2, 2009.
6. Carville S.F., Arendt-Nielsen S., Bliddal H. et al. EULAR evidence-based recommendations for the management of fi bromyalgia syndrome. Ann Rheum Dis. 2008; 67(4): 536–541.
7. Clauw D.J. Fibromyalgia: an overview. Am J Med. 2009; 12(suppl1): 3-13.
8. Crofford LJ. Pharmaceutical treatment options for fibromyalgia. Curr Rheumatol Rep. 2004; 6(4): 274–280.
9. Fibromyalgia Syndrome Pain Management Guideline Panel 2002-2005. In: Buckhardt C., Goldenberg D. et al. Guideline for the Management of Fibromyalgia Syndrome Pain in Adults and Children: APS Clinical Practice Guidelines Series. No. 4, Glenview, IL: American Pain Society; 2005.
10. Goldenberg D.L., Burckhardt C., Croff ord L. Management of fibromyalgia syndrome. JAMA. 2004; 292(19): 2388–2395.
11. Hauser W., Bernardy K., Uceyler N., Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA. 2009;301:198-209.
12. Moldofsky H., Scarisbrick P., England R.,Smythe H.A. Musculosceletal symptoms and non-REM sleep disturbance in patients with «fi brositis syndrome» and healthy subjects. Psychosom Med. 1975;37:341-351.
13. 13. Recla J.M. New and emerging therapeutic agents for the treatment of fi bromyalgia: an update. J Pain Res. 2010; 3: 89–103.
14. Sicras-Mainar A., Rejas J., Navarro R., Blanca M., Morcillo A., Larios R., Velasso S., Villarroya C: Treating patients with fi bromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthriria Res Ther 2009;11:R54.
15. Smythe H.A. «Fibrositis» as a disorder of pain modulation. Clin Rheum Dis. 1979;5:823-832.
16. Weir P.T., Harlan G.A., Nkov F.L. The incidence of fibromyalgia and its associated comorbidities: a populationbased retrospective cogort study based on International Classifi cation of Diseases, 9th Revision codes. J Clin Rheumatol. 2006, Jun; 12(3):124-8.
17. White K.P., Speechley M., Hart M., Ostbye T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol. 1999;26:1570-1576.
18. White K.P., Thompson J. Fibromyalgia syndrome in an Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol. 2003;30:1835-1840.
19. Wolfe F., Ross K., Anderson J., Russel I.J. Aspects of fibromyalgia in general population: sex, pain threshold, and fi bromyalgia symptoms. J Rheumatol. 1995;22:151-156.
20. Wolfe F., Smithe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 Criteria for the Classifi cation of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160-172.
21. Wolfe F., Ross K., Anderson J et al. The prevalence and characteristics of fi bromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
22. Wolfe F., Clauw D.J., Fitzcharles M.A., Goldenberg D.L., Häuser W., Katz R.S., Mease P., Russell A.S., Russell I.J., Winfield J.B. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia // J. Rheumatol. 2011. Jun; 38(6): 1113–1122.
评论
浏览:
409
Email this article 